Kopin (NASDAQ:KOPN – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $3.00 to $3.25 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 27.20% from the company’s […]

Mineralys Therapeutics (NASDAQ:MLYS – Free Report) had its price target hoisted by HC Wainwright from $52.00 to $56.00 in a research report sent to investors on Wednesday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other research analysts also recently issued reports on MLYS. Wall Street Zen raised shares […]

Voyager Therapeutics (NASDAQ:VYGR – Free Report) had its target price reduced by HC Wainwright from $30.00 to $25.00 in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. A number of other research firms have also recently commented on VYGR. Weiss Ratings restated a “sell (d)” […]

Telsey Advisory Group reaffirmed their outperform rating on shares of Steven Madden (NASDAQ:SHOO – Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $45.00 price objective on the textile maker’s stock. Telsey Advisory Group also issued estimates for Steven Madden’s Q4 2025 earnings at $0.46 EPS, Q2 2026 earnings […]

Home Depot (NYSE:HD – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Telsey Advisory Group in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $455.00 price target on the home improvement retailer’s stock. Telsey Advisory Group’s price objective indicates a potential upside of 22.68% […]

Rockwell Medical (NASDAQ:RMTI – Get Free Report) had its price target reduced by HC Wainwright from $3.00 to $2.50 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target would indicate a potential upside of 171.15% from the stock’s previous close. […]

uniQure (NASDAQ:QURE – Free Report) had its target price cut by Wells Fargo & Company from $80.00 to $60.00 in a report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. Guggenheim increased their price objective on shares […]